| abstract |
Disclosed is a compound for a drug combination therapy for cancer. To a subject in need of treatment for cancer, (i) a first therapeutic agent comprising compound (1) or a pharmaceutically acceptable salt thereof, (Ii) A treatment method comprising administering in combination with a second therapeutic agent, wherein the first therapeutic agent and the second therapeutic agent are administered simultaneously or sequentially. [Selection] Figure 1 |